ADM Stock Analysis: Archer-Daniels-Midland | NYSE
Farm Products | NYSE, USA | Market Cap: 36.913m USD | 12M Return: 38.2% | US0394831020 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 322M
EPS Trend: -90.4%
Qual. Beats: 1
Rev. Trend: -94.9%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Archer-Daniels-Midland Company (ADM) is a global agribusiness that produces human and animal nutrition ingredients and solutions, operating in three main segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. The companys operations span the United States, Switzerland, the Cayman Islands, Brazil, Mexico, Canada, the United Kingdom, and other international markets, encompassing the origination, merchandising, transportation, and storage of agricultural raw materials, as well as the crushing and processing of oilseeds such as soybeans, cottonseed, sunflower, canola, rapeseed, and flaxseed. ADM also engages in corn and wheat wet and dry milling, producing distillers grains and corn gluten products for animal feed, while its Nutrition segment manufactures plant-based proteins, flavors, colors, emulsifiers, hydrocolloids, probiotics, prebiotics, postbiotics, enzymes, and botanical extracts for food and feed applications. The company is also involved in structured trade finance, carbon capture and sequestration initiatives, derivatives trading, and insurance coverage for various risks. Founded in 1902 and headquartered in Chicago, Illinois, ADM has been publicly traded since its 1983 IPO.
As a member of the dominant group of global agricultural commodity traders (often referred to as the ABCD companies alongside Bunge, Cargill, and Louis Dreyfus), ADM operates within the Consumer Staples sector, classified under Agricultural Products & Services, benefiting from relatively stable demand driven by food, feed, and biofuel end markets.
- Soybean crush margins track global supply and renewable diesel demand
- Nutrition segment margins expand on specialty ingredient pricing power
- Biofuel mandates and ethanol demand lift Carbohydrate Solutions revenue
| Net Income: 1.77b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -4.77 > 1.0 |
| NWC/Revenue: 9.48% < 20% (prev 9.45%; Δ 0.04% < -1%) |
| CFO/TA 0.05 > 3% & CFO 2.79b > Net Income 1.77b |
| Net Debt (1.06b) to EBITDA (3.21b): 0.33 < 3 |
| Current Ratio: 1.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (485.0m) vs 12m ago 0.21% < -2% |
| Gross Margin: 6.87% > 18% (prev 5.92%; Δ 0.95% > 0.5%) |
| Asset Turnover: 155.6% > 50% (prev 159.2%; Δ -3.64% > 0%) |
| Interest Coverage Ratio: 3.41 > 6 (EBIT TTM 2.02b / Interest Expense TTM 592.0m) |
| A: 0.15 (Total Current Assets 27.8b - Total Current Liabilities 20.0b) / Total Assets 53.5b |
| B: 0.42 (Retained Earnings 22.7b / Total Assets 53.5b) |
| C: 0.04 (EBIT TTM 2.02b / Avg Total Assets 52.8b) |
| D: 0.80 (Book Value of Equity 23.6b / Total Liabilities 29.7b) |
| Altman-Z'' = 3.43 = A |
| DSRI: 1.26 (Receivables 7.26b/5.80b, Revenue 82.1b/82.8b) |
| GMI: 0.86 (GM 5.92% / 6.87%) |
| AQI: 0.99 (AQ_t 0.25 / AQ_t-1 0.25) |
| SGI: 0.99 (Revenue 82.1b / 82.8b) |
| TATA: -0.02 (NI 1.77b - CFO 2.79b) / TA 53.5b) |
| Beneish M = -2.95 (Cap -4..+1) = A |
As of August 14, 2026, the stock is trading at USD 80.15 with a total of 2,068,065 shares traded. Over the past week, the price has changed by +3.41%, over one month by -2.30%, over three months by -2.67% and over the past year by +38.21%.
Current recommended Stop Loss: 77.10 (which is 3.8% or 1.3 ATR below the current price).
Archer-Daniels-Midland has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold ADM.
- StrongBuy: 1
- Buy: 0
- Hold: 9
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 78.7 | -1.8% |
P/E Trailing = 20.9262
P/E Forward = 15.3374
P/S = 0.4725
P/B = 1.5659
P/EG = 0.9957
Revenue TTM = 82.1b USD
EBIT TTM = 2.02b USD
EBITDA TTM = 3.21b USD
Long Term Debt = 6.45b USD (from longTermDebt, last quarter)
Short Term Debt = 1.86b USD (from shortTermDebt, last quarter)
Debt = 10.7b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.33b
Net Debt = 1.06b USD (calculated: Debt 10.7b - CCE 9.61b)
Enterprise Value = 38.0b USD (36.9b + Debt 10.7b - CCE 9.61b)
Interest Coverage Ratio = 3.41 (Ebit TTM 2.02b / Interest Expense TTM 592.0m)
EV/FCF = 22.65x (Enterprise Value 38.0b / FCF TTM 1.68b)
FCF Yield = 4.42% (FCF TTM 1.68b / Enterprise Value 38.0b)
FCF Margin = 2.04% (FCF TTM 1.68b / Revenue TTM 82.1b)
Net Margin = 2.16% (Net Income TTM 1.77b / Revenue TTM 82.1b)
Gross Margin = 6.87% ((Revenue TTM 82.1b - Cost of Revenue TTM 76.5b) / Revenue TTM)
Gross Margin QoQ = 8.53% (prev 5.96%)
Tobins Q-Ratio = 0.71 (Enterprise Value 38.0b / Total Assets 53.5b)
Interest Expense / Debt = 5.55% (Interest Expense 592.0m / Debt 10.7b)
Taxrate = 15.08% (316.0m / 2.10b)
NOPAT = 1.72b (EBIT 2.02b * (1 - 15.08%))
Current Ratio = 1.39 (Total Current Assets 27.8b / Total Current Liabilities 20.0b)
Debt / Equity = 0.45 (Debt 10.7b / totalStockholderEquity, last quarter 23.6b)
Debt / EBITDA = 0.33 (Net Debt 1.06b / EBITDA 3.21b)
Debt / FCF = 0.63 (Net Debt 1.06b / FCF TTM 1.68b)
Total Stockholder Equity = 22.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.35% (Net Income 1.77b / Total Assets 53.5b)
RoE = 7.73% (Net Income TTM 1.77b / Total Stockholder Equity 22.9b)
RoCE = 6.88% (EBIT 2.02b / Capital Employed (Equity 22.9b + L.T.Debt 6.45b))
RoIC = 5.49% (NOPAT 1.72b / Invested Capital 31.3b)
WACC = 5.85% (E(36.9b)/V(47.6b) * Re(6.18%) + D(10.7b)/V(47.6b) * Rd(5.55%) * (1-Tc(0.15)))
Discount Rate = 6.18% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -62.89 | Cagr: -2.55%
[DCF] Terminal Value 73.10% ; FCFF base≈2.65b ; Y1≈2.32b ; Y5≈1.88b
[DCF] Fair Price = 60.32 (EV 30.1b - Net Debt 1.06b = Equity 29.1b / Shares 482.0m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -90.42 | EPS CAGR: -24.05% | SUE: 4.0 | # QB: 1
Revenue Correlation: -94.92 | Revenue CAGR: -6.26% | SUE: -0.47 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.54 | Chg30d=+18.60% | Revisions=+38% | Analysts=6
EPS current Year (2026-12-31): EPS=5.49 | Chg30d=+19.39% | Revisions=+38% | GrowthEPS=+60.1% | GrowthRev=+5.2%
EPS next Year (2027-12-31): EPS=5.68 | Chg30d=+5.78% | Revisions=+44% | GrowthEPS=+3.5% | GrowthRev=+6.4%
[Analyst] Revisions Ratio: +53% (up=13, down=3)